Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 29.1B | 27.6B | 28.3B | 28.2B |
Cost of revenue | 7.3B | 6.7B | 6.8B | 6.9B |
Gross profit | 21.8B | 20.9B | 21.5B | 21.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.0B | 6.7B | 7.3B | 7.1B |
Operating income | 7.6B | 7.2B | 7.4B | 7.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 560M | 570M | 640M | 750M |
Other income expense | — | — | — | — |
Pretax income | 6.7B | 6.9B | 6.6B | 6.6B |
Tax provision | 1.7B | 1.9B | 2.1B | 2.0B |
Net income | 5.0B | 5.0B | 4.5B | 4.6B |
Basic EPS | — | 14.9 | 13.4 | 13.5 |
Diluted EPS | — | 14.9 | 13.4 | 13.5 |
Basic average shares | — | 338.0M | 338.8M | 338.3M |
Diluted average shares | — | 338.0M | 338.8M | 338.3M |
EBITDA | 9.5B | 9.5B | 9.2B | 9.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |